Trinity Biotech plc（TRIB）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · TRIB · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$43.92M	$61.55M	$56.83M	$62.52M	$81.15M
Cost of Revenue	$28.37M	$40.11M	$37.38M	$52.73M	$54.89M
Gross Profit	$15.55M	$21.44M	$19.45M	$22.05M	$33.45M
Gross Margin %(computed)	35.40%	34.83%	34.22%	35.26%	41.23%
Operating Expenses
R&D Expenses	$3.64M	$4.54M	$4.38M	$4.14M	$4.50M
G&A Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$24.68M
Total Operating Expenses	$26.51M	$42.61M	$46.49M	$32.96M	$29.52M
Operating Income	($10.96M)	($21.16M)	($27.05M)	($15.27M)	$3.94M
Operating Margin %(computed)	-24.94%	-34.38%	-47.59%	-24.42%	4.85%
Interest Income	$0.00M	$0.00M	$1.17M	$0.30M	$1.22M
Interest Expense	$21.45M	$9.56M	$10.15M	$24.73M	$7.10M
Income Before Tax	($37.29M)	($30.73M)	($36.93M)	($43.78M)	($1.92M)
Income Tax Expense	$0.20M	$0.49M	($0.06M)	($0.19M)	($0.07M)
Net Income	($37.49M)	($31.79M)	($24.02M)	($41.00M)	$0.88M
Net Margin %(computed)	-85.36%	-51.64%	-42.26%	-65.58%	1.08%
Per Share & EBITDA
EPS (Basic)	$-2.00	$-1.77	$-3.20	$-6.00	$0.21
Wtd Avg Shares	18.58M	17.96M	7.65M	6.75M	4.18M
EBITDA	($8.26M)	($16.91M)	($24.10M)	($16.71M)	$10.59M
EBITDA Margin %(computed)	-18.81%	-27.46%	-42.40%	-26.73%	13.05%